Committed to Medical Innovations
Every day—in research labs across eastern Massachusetts—investigators, doctors and nurses at Mass General Brigham are working to discover new treatment options, medical devices and technology to improve the lives and outcomes of patients. Mass General Brigham Innovation works directly with researchers at Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital, and Spaulding Hospital to commercialize their innovations. It is our mission to enable commercialization through the best route for a given technology and ensure that technologies can benefit patients.
Innovator’s Commercialization and Quick Start Guides
Mass General Brigham continues to prioritize the growth and efficiency of innovation and collaboration throughout our system. In support of this goal, Innovation has prepared the enclosed guide for employees interested in Mass General Brigham’s commercialization process. This guide is intended to help orient both new and experienced innovators to policies and procedure from the simple question of ‘who do I contact?’ to the more complex situations involving intellectual property, contracting, conflicts, and funding. As always, please contact the Innovation team with any questions about this process.
Inquiries for Intellectual Property and Research Collaborations
We welcome queries from industry regarding potential research collaborations and/or licensing of intellectual property from Innovation’s affiliated Hospitals. Please email us with a brief summary of your area(s) of interest and a member of the Licensing team will respond shortly. Thank you.
The Innovation Fellows Program enables personnel exchanges between Mass General Brigham hospitals and the participating industry. Biopharmaceutical, device, venture capital, digital health, payors, and consulting firms engage with early career Harvard faculty and trainees appointed at Brigham and Women’s Hospital, Massachusetts General Hospital, and McLean Hospital. Fellows gain the competencies they need to become future leaders in health care through experiential opportunities.
Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer,…
Game-changing biotech innovations include new delivery system for brain cancer therapeutics, better detection of potential pregnancy complications,…
Mass General Brigham AI and Digital Innovation Fund Invests in DexCare Series B – Technology offers data-driven management of access to care
DexCare, Inc., a data-driven intelligence company focused on healthcare access, today announced a $50M Series B funding…
Want the latest information on all things Innovation? Simply enter your email address to start receiving our news and announcements.